Donohue IF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:499-508.
Donohue JF, Ganapathy V, Bollu V, Stensland MD, Nelson LM. Health status of patients with moderate to severe COPD after treatment with nebulized arformoterol tartrate or placebo for 1 year. Clin Ther. 2017 Jan;39(1):66-74. doi: 10.1016/j.clinthera.2016.11.021
Mytelka DS, Lorenzo M, Stafkey-Mailey D, D’yachkova Y, Nagar S, Candrilli SD, Kaye JA. Advanced soft tissue sarcoma: systemic treatment patterns and survival in Germany. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 2, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A760.
Donohue J, Ganapathy V, Davenport E, Nelson L, Zhao X. COPD-related hospitalizations associated with arformoterol tartrate treatment among patients receiving concomitant tiotropium (TIO) therapy: post hoc analyses from a 52-week randomized, controlled study. Poster presented at the CHEST 2016 Annual Meeting; October 24, 2016. Los Angeles, CA. [abstract] Chest. 2016 Oct; 150(4_S). doi: 10.1016/j.chest.2016.08.990
Donohue J, Ganapathy V, Nelson L, Zhou X. Health-related quality of life among patients who experienced prior COPD-related exacerbations: post hoc analysis of a 52-week randomized placebo-controlled trial of nebulized arformoterol tartrate. Poster presented at the 2016 American Thoracic Society Annual Conference; May 18, 2016. San Francisco, CA.
Donohue J, Ganapathy V, Zhou X, Nelson L. Chronic obstructive pulmonary disease (COPD)-related hospitalizations by health status response among patients receiving arformoterol tartrate or placebo: post hoc analyses from a 52-week randomized, controlled study. Poster presented at the 2016 American Thoracic Society Annual Conference; May 15, 2016. San Francisco, CA.
Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000 Mar;11(2):185-8.